Mayo Clinic: Diarrhea trials

The registry lists 13 Diarrhea studies with Mayo Clinic as lead sponsor. 2 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 2 6Phase 3 3Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a NeuromodulatorRecruitingNCT06684470Early Phase 1
• Enabling Microbiomics- Driven Personalized NutritionEnrolling by invitationNCT06657001
• Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid MalabsorptionCompletedNCT03270085Phase 2Results posted
• Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCTTerminatedNCT02619812Phase 2Results posted
• Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-DTerminatedNCT02239926Phase 2/3Results posted
• Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile AcidsCompletedNCT02111603Phase 4Results posted
• Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)?CompletedNCT00911612Phase 2Results posted
• Budesonide Versus Placebo for the Treatment of Lymphocytic ColitisTerminatedNCT00217022Phase 2/3Results posted
• A Study of Hemp Hull WFI for IBS DiarrheaCompletedNCT06028035Not applicable
• Analyzing IBS to Identify Biomarkers and Microbiome SignaturesCompletedNCT02419963Not applicable
• Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-DCompletedNCT02163213Not applicable
• Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel SyndromeCompletedNCT01094041Not applicable
• Trial of Mesalamine for the Treatment of Active Microscopic ColitisCompletedNCT00952952Phase 2/3